Once CLL cells move into circulation they would then recover from antigen engagement and upregulate surface IgM and CXCR4 expression potentially enhancing their ability to reenter tissues and undergo proliferative/prosurvival signals that include BCR engagement as has been proposed [115, 145]. The gene discussed is BCR; the disease is B-cell chronic lymphocytic leukemia.